AIM ImmunoTech, Inc. (AIM) - Yakuniy foyda

AIM (AIM ImmunoTech, Inc.) - kompaniyaning tovar belgisi

AIM ImmunoTech daromadlari onkologiya va kam uchraydigan patologiyalarni davolash uchun Ampligen mahsulotining tijoratlashtirilishiga asoslangan. Ushbu grafikdagi kompaniyaning umumiy sof foydasi moliyaviy rentabellikni vizuallashtiradi, bunda joriy holat -0.01 ga tengdir. Biznes immunologik bozorga va post-viral bemorlarga yordam ko'rsatishga e'tibor qaratadi. Hozirgi vaqtda Ampligen platformasi yetuklik bosqichiga yetdi, bu esa yangi tartibga soluvchi tasdiqlashlar uchun klinik bazani kengaytirish imkonini beradi.

AIM AIM ImmunoTech Kompaniyaning sof foydasi (04.07.2022 - 29.10.2026)

AIM ImmunoTech Inc. (AIM) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- bozor qiymati va tahlilchilarning maqsadli prognozi:
Aksiya narxi aimimmuno.com|AIM - Konsensus maqsadli narx
- bozor kapitallashuvi ko'rsatkichlari:
Bozor qiymati AIM ImmunoTech Inc.|AIM - Korxona qiymati
- biznesning balans baholash tafsilotlari:
Aksiya hisobiga sof aktivlar AIM ImmunoTech|AIM - Kompaniyaning balans qiymati|Kapitallashuvning sof aktivlarga nisbati aimimmuno.com|AIM - Kompaniyaning jami aktivlari
- qarz yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning xususiy kapitalga nisbati AIM ImmunoTech|AIM - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati AIM ImmunoTech, Inc.|AIM - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati AIM ImmunoTech Inc.|AIM - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz AIM ImmunoTech|Tezkor likvidlik koeffitsiyenti aimimmuno.com
- foyda va multiplikatorlar bo'yicha ma'lumotlar:
AIM - Sof foyda
Kompaniyaning asosiy tahlili:aimimmuno.com
AIM ImmunoTech Inc. asosiy tovari

Fundamental yetakchilarni aniqlash uchun tahlilchi barcha xarajatlardan keyingi yakuniy moliyaviy natija sifatida sof foydani baholaydi, bunda muntazam kamayishlar yashirin operatsion xatarlardan dalolat beradi. AIM ImmunoTech (AIM) holatida, ushbu ko'rsatkich immunomodulyatorlar bo'yicha patent monopoliyalarining monetizatsiya samaradorligini aks ettiradi va kompaniyaning foyda grafigi orqali doimiy R&D xarajatlaridan o'ta yuqori marjali sotuvlarga o'tishni baholash imkonini beradi.

Toʻgʻridan-toʻgʻri raqobatchilar

argenx BVBA (ARGX) - Sof foyda|Sof daromad BNTX|ABVX: Yakuniy foyda|Sof foyda ADMA|Sof moliyaviy natija Protagonist Therapeutics, Inc.|Kompaniyaning sof foydasi Immunovant Corp IMVT|KNSA - Sof daromad|GRFS - Kompaniyaning sof foydasi|adaptivebiotech.com (ADPT) - Sof daromad|CLDX (Celldex Therapeutics, Inc.) - Sof daromad|Aurinia Pharmaceuticals Inc (AUPH) - Sof foyda|Kompaniyaning sof foydasi BioCryst Pharmaceuticals Inc|Kompaniya foydasi VERA (Vera Corp)|Sof foyda DNTH|PHVS - Kompaniyaning sof daromadi|Sof foyda ABCL (AbCellera Biologics Inc)|Sof foyda Tourmaline Bio Inc TRML|Intrexon - Sof foyda|Sof moliyaviy natija Pharming Corp PHAR|Nektar Therapeutics (NKTR) - Kompaniyaning sof foydasi|Sof daromad upstreambio.com|Sof daromad ZBIO|IMNM: Yakuniy foyda|Sof foyda GOSS|Sof moliyaviy natija KalVista Corp|Kompaniyaning sof foydasi Septerna Inc SEPN|PVLA - Sof daromad|SVRA - Kompaniyaning sof foydasi|Rigel Pharma (RIGL) - Sof daromad|ANAB (AnaptysBio Corp) - Sof daromad|Astria Corp (ATXS) - Sof foyda|Kompaniyaning sof foydasi enGene Holdings Inc.|Kompaniya foydasi RAPT (rapt.com)|Kompaniyaning sof foydasi Aerovate Therapeutics Inc (JBIO)|ACRS - Kompaniyaning sof daromadi|Kyverna - Sof daromad|Soliqlar to‘langandan keyingi foyda TLSA (Tiziana Life Sciences, Ltd.)|Cabaletta Bio, Inc. - Sof foyda|Kompaniyaning sof daromadi ventyxbio.com|THTX: Sof foyda|Sof daromad Avalo Therapeutics, Inc.|ELDN (Eledon) - Sof foyda|AGEN: Yakuniy foyda|Sof foyda CLYM|Sof foyda zurabio.com (ZURA)|Sof foyda ATYR (aTyr Pharma)|Sof moliyaviy natija Adagene Inc (ADAG)|IMA - Kompaniyaning sof foydasi|Shattuck Labs, Inc. (STTK) - Sof daromad|equilliumbio.com (EQ) - Kompaniyaning sof foydasi|Soliqdan keyingi foyda CNTB (Connect Biopharma Holdings Limited)|IMUX (Immunic Therapeutics) - Sof foyda|ATRA: Yakuniy foyda|Sof foyda IFRX|Sof foyda X4 Pharmaceuticals, Inc (XFOR)|Kompaniyaning sof foydasi Adicet Bio, Inc. ACET|Yakuniy foyda CELU|INMB - Kompaniyaning sof foydasi|Barinthus Biotherapeutics PLC (BRNS) - Sof daromad|KZR: Sof foyda|SAB Biotherapeutics Inc (SABS) - Sof foyda|Sof daromad AKTX|ENLV: Yakuniy foyda|Sof foyda QTTB|Sof moliyaviy natija GeoVax Labs|Kompaniyaning sof foydasi Edesa EDSA|IBIO - Sof daromad|CARM - Kompaniyaning sof foydasi|xtlbio.com (XTLB) - Sof daromad|BOLT (boltbio.com) - Sof daromad|HCW Biologics (HCWB) - Sof foyda|Kompaniyaning sof foydasi Aptevo Therapeutics, Inc.|Kompaniya foydasi ADTX (Aditxt Corp)|Sof foyda GRI|XRTX - Kompaniyaning sof daromadi|Sof foyda HIND (Vyome Holdings)|Sof foyda Revelation Biosciences Inc REVB|Indaptus - Sof foyda|Sof moliyaviy natija BiondVax Pharmaceuticals SCNI|calcimedica.com (CALI) - Kompaniyaning sof foydasi|Sof daromad Affimed N.V.|Sof daromad ALLK|HOOK: Yakuniy foyda|Sof foyda IGMS|Sof moliyaviy natija iTeos Pharma|Kompaniyaning sof foydasi Ocean Biomedical, Inc. OCEA|TCBP - Sof daromad|THRD - Kompaniyaning sof foydasi